Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA

Molecular Cancer Research

Volumn 5, Issue 10, 2007, Pages 1099-1109

  Tabu, Kouichi ^a   Ohba, Yusuke ^a   Suzuki, Tadaki ^b   Makino, Yoshinori ^b   Kimura, Taichi ^a   Ohnishi, Akiko ^c   Sakai, Mieko ^a   Watanabe, Takuya ^a   Tanaka, Shinya ^a   Sawa, Hirofumi ^b  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; EXOENZYME C3; GUANOSINE TRIPHOSPHATASE; HELIX LOOP HELIX PROTEIN; MESSENGER RNA; OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CELL MOTILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE ACTIVATION; GENE INDUCTION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; INHIBITION KINETICS; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; STRESS FIBER; TUMOR CELL LINE; UPREGULATION;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GLIOMA; GTPASE-ACTIVATING PROTEINS; HUMANS; NERVE TISSUE PROTEINS; RHOA GTP-BINDING PROTEIN; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 35948937181     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-07-0096     Document Type: Article

References (78)

1. Lu QR, Yuk D, Alberta JA, et al. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 2000;25:317-29.
2. Takebayashi H, Yoshida S, Sugimori M, et al. Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3. Mech Dev 2000;99:143-8.
3. Zhou Q, Wang S, Anderson DJ. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 2000;25:331-43.
4. Zhou Q, Choi G, Anderson DJ. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 2001;31:791-807.
5. Ligon KL, Fancy SP, Franklin RJ, Rowitch DH. Olig gene function in CNS development and disease. Glia 2006;54:1-10.
6. Ligon KL, Kesari S, Kitada M,et al. Development of NG2 neural progenitor cells requires Olig gene function. Proc Natl Acad Sci U S A 2006;103:7853-8.
7. Lu QR, Park JK, Noll E, et al. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors. Proc Natl Acad Sci U S A 2001;98:10851-6.
8. Marie Y, Sanson M, Mokhtari K, et al. OLIG2 as a specific marker of oligodendroglial tumour cells. Lancet 2001;358:298-300.
9. Yokoo H, Nobusawa S, Takebayashi H, et al. Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol 2004;164:1717-25.
10. Aguirre-Cruz L, Mokhtari K, Hoang-Xuan K, et al. Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors. J Neurooncol 2004;67:265-71.
11. Ligon KL, Alberta JA, Kho AT, et al. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol 2004;63:499-509.
12. Mokhtari K, Paris S, Aguirre-Cruz L,et al. Olig2 expression, GFAP,p53 and 1p loss analysis contribute to glioma subclassification. Neuropathol Appl Neurobiol 2005;31:62-9.
13. Ohnishi A, Sawa H, Tsuda M, et al. Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas. J Neuropathol Exp Neurol 2003;62:1052-9.
14. Tabu K, Ohnishi A, Sunden Y, et al. A novel function of OLIG2 to suppress human glial tumor cell growth via p27Kip1 transactivation. J Cell Sci 2006;119: 1433-41.
15. Wennerberg K, Der CJ. Rho-family GTPases: it's not only Rac and Rho (and I like it). J Cell Sci 2004;117:1301-12.
16. Prendergast GC, Khosravi-Far R, Solski PA, Kurzawa H, Lebowitz PF, Der CJ. Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 1995;10:2289-96.
17. Qiu RG, Chen J, McCormick F, Symons M. A role for Rho in Ras transformation. Proc Natl Acad Sci U S A 1995;92:11781-5.
18. Lin R, Bagrodia S, Cerione R, Manor D. A novel Cdc42Hs mutant induces cellular transformation. Curr Biol 1997;7:794-7.
19. Keely PJ, Westwick JK, Whitehead IP, Der CJ, Parise LV. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 1997;390:632-6.
20. Chan AY, Coniglio SJ, Chuang YY, et al. Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion. Oncogene 2005;24:7821-9.
21. Bouzahzah B, Albanese C, Ahmed F, et al. Rho family GTPases regulate mammary epithelium cell growth and metastasis through distinguishable pathways. Mol Med 2001;12:816-30.
22. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002;2:133-42.
23. Raftopoulou M, Hall A. Cell migration: Rho GTPases lead the way. Dev Biol 2004;265:23-32.
24. Nakada M, Okada Y, Yamashita J. The role of matrix metalloproteinases in glioma invasion. Front Biosci 2003;8:e261-9.
25. Kunishio K, Okada M, Matsumoto Y, Nagao S. Matrix metalloproteinase-2 and -9 expression in astrocytic tumors. Brain Tumor Pathol 2003;20:39-45.
26. Levicar N, Nuttall RK, Lah TT, Nutall RK. Proteases in brain tumour progression. Acta Neurochir (Wien) 2003;145:825-38.
27. Thorns V, Walter GF, Thorns C. Expression of MMP-2, MMP-7, MMP-9 , MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 2003;23:937-44.
28. Wang M, Wang T, Liu S, Yoshida D, Teramoto A. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol 2003;20:65-72.
29. Komatsu K, Nakanishi Y, Nemoto N, Hori T, Sawa da T, Kobayashi M. Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathol 2004;21:105-12.
30. Guo P, Imanishi Y, Cackowski FC, et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5g2 correlates with the invasiveness of human glioma. Am J Pathol 2005;166:877-90.
31. Frolichsthal-Schoeller P, Vescovi AL, Krekoski CA, Murphy G, Edwards DR, Forsyth P. Expression and modulation of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinases in human embryonic CNS stem cells. Neuroreport 1999;10:345-51.
32. Ridley AJ. Rho GTPases and cell migration. J Cell Sci 2001;114:2713-22.
33. Narumiya S, Ishizaki T, Watanabe N. Rho effectors and reorganization of actin cytoskeleton. FEBS Lett 1997;410:68-72.
34. Ilic D, Furuta Y, Kanazawa S, et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995;377:539-44.
35. Ren XD, Kiosses WB, Sieg DJ, Otey CA, Schlaepfer DD, Schwartz MA. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J Cell Sci 2000;113:3673-8.
36. Arthur WT, Burridge K. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 2001;12:2711-20.
37. Cox EA, Sastry SK, Huttenlocher A. Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the Rho family of GTPases. Mol Biol Cell 2001;12:265-77.
38. Sugimoto N, Takuwa N, Okamoto H, Sakurada S, Takuwa Y. Inhibitory and stimulatory regulation of Rac and cell motility by the G12/13-Rho and Gi pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 2003;23:1534-45.
39. Vial E, Sahai E, Marshall CJ. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 2003;4:67-79.
40. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004;18:862-76.
41. Zheng Y. Dbl family guanine nucleotide exchange factors. Trends Biochem Sci 2001;26:724-32.
42. Moon SY, Zheng Y. Rho GTPase-activating proteins in cell regulation. Trends Cell Biol 2003;13:13-22.
43. Wilde C, Chhatwal GS, Schmalzing G, Aktories K, Just I. A novel C3-like ADP-ribosyltransferase from Staphylococcus aureus modifying RhoE and Rnd3. J Biol Chem 2001;276:9537-42.
44. Flatau G, Lemichez E, Gauthier M, et al. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 1997;387:729-33.
45. Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, Aktories K. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 1997;387:725-9.
46. Pertz O, Hahn KM. Designing biosensors for Rho family proteins deciphering the dynamics of Rho family GTPase activation in living cells. J Cell Sci 2004;117:1313-8.
47. Yoshizaki H, Ohba Y, Kurokawa K,et al. Activity of Rho-family GTPases during cell division as visualized with FRET-based probes. J Cell Biol 2003;162:223-32.
48. Pertz O, Hodgson L, Klemke RL, Hahn KM. Spatiotemporal dynamics of RhoA activity in migrating cells. Nature 2006;440:1069-72.
49. Mitchison TJ, Cramer LP. Actin-based cell motility and cell locomotion. Cell 1996;84:371-9.
50. Kaibuchi K, Kuroda S, Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 1999;68:459-86.
51. Amano M, Fukata Y, Kaibuchi K. Regulation and functions of Rho-associated kinase. Exp Cell Res 2000;261:44-51.
52. Fujiwara T, Mammoto A, Kim Y, Takai Y. Rho small G-protein-dependent binding of mDia to an Src homology 3 domain-containing IRSp53/BAIAP2. Biochem Biophys Res Commun 2000;271:626-9.
53. Suetsugu S, Kurisu S, Oikawa T, Yamazaki D, Oda A, Takenawa T. Optimization of WAVE2 complex-induced actin polymerization by membrane-bound IRSp53, PIP(3), and Rac. J Cell Biol 2006;173:571-85.
54. Ridley AJ. Rho proteins and cancer. Breast Cancer Res Treat 2004;84:13-9.
55. Somlyo AV, Bradshaw D, Ramos S, Murphy C, Myers CE, Somlyo AP. Rhokinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun 2000;269:652-9.
56. Nakajima M, Hayashi K, Egi Y, et al. Effect of Wf-536, a novel ROCK inhibitor,again st metastasis of B16 melanoma. Cancer Chemother Pharmacol 2003;52:319-24.
57. Forget MA, Desrosiers RR, Del M, et al. The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clin Exp Metastasis 2002;19:9-15.
58. Salhia B, Rutten F, Nakada M, et al. Inhibition of Rho-kinase affects astrocytoma morphology,motility ,and invasion through activation of Rac1. Cancer Res 2005;65:8792-800.
59. Annabi B, Bouzeghrane M, Moumdjian R, Moghrabi A, Béliveau R. Probing the infiltrating character of brain tumors: inhibition of RhoA/ROK-mediated CD44 cell surface shedding from glioma cells by the green tea catechin EGCg. J Neurochem 2005;94:906-16.
60. Takaishi K, Kikuchi A, Kuroda S, Kotani K, Sasaki T, Takai Y. Involvement of rho p21 and its inhibitory GDP/GTP exchange protein (rho GDI) in cell motility. Mol Cell Biol 1993;13:72-9.
61. Ridley AJ, Comoglio PM, Hall A. Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol Cell Biol 1995;15:1110-22.
62. DiMilla PA, Barbee K, Lauffenburger DA. Mathematical model for the effects of adhesion and mechanics on cell migration speed. Biophys J 1991;60:15-37.
63. Gupton SL, Waterman-Storer CM. Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell 2006;125:1361-74.
64. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005;33:891-5.
65. Lua BL, Low BC. BPGAP1 interacts with cortactin and facilitates its translocation to cell periphery for enhanced cell migration. Mol Biol Cell 2004;15:2873-83.
66. Lua BL, Low BC. Filling the GAPs in cell dynamics control: BPGAP1 promotes cortactin translocation to the cell periphery for enhanced cell migration. Biochem Soc Trans 2004;32:1110-2.
67. Doetsch F. The glial identity of neural stem cells. Nat Neurosci 2003;6:1127-34.
68. Ross SE, Greenberg ME, Stiles CD. Basic helix-loop-helix factors in cortical development. Neuron 2003;39:13-25.
69. Fukuda S, Kondo T, Takebayashi H, Taga T. Negative regulatory effect of an oligodendrocytic bHLH factor OLIG2 on the astrocytic differentiation pathway. Cell Death Differ 2004;11:196-202.
70. Muroyama Y, Fujiwara Y, Orkin SH, Rowitch DH. Specification of astrocytes by bHLH protein SCL in a restricted region of the neural tube. Nature 2005;438:360-3.
71. Ramakers GJ, Moolenaar WH. Regulation of astrocyte morphology by RhoA and lysophosphatidic acid. Exp Cell Res 1998;245:252-62.
72. Kalman D, Gomperts SN, Hardy S, Kitamura M, Bishop JM. Ras family GTPases control growth of astrocyte processes. Mol Biol Cell 1999;10:1665-83.
73. Chen CJ, Liao SL, Huang YS, Chiang AN. RhoA inactivation is crucial to manganese-induced astrocyte stellation. Biochem Biophys Res Commun 2005;326:873-9.
74. Chen CJ, Ou YC, Lin SY, Liao SL, Huang YS, Chiang AN. L-Glutamate activates RhoA GTPase leading to suppression of astrocyte stellation. Eur J Neurosci 2006;23:1977-87.
75. Defilippi P, Truffa G, Stefanuto G, Altruda F, Silengo L, Tarone G. Tumor necrosis factor a and interferon γ modulate the expression of the vitronectin receptor (integrin h3) in human endothelial cells. J Biol Chem 1991;266:7638-45.
76. Tsuda M, Makino Y, Iwahara T, et al. Crk associates with ERM proteins and promotes cell motility toward hyaluronic acid. J Biol Chem 2004;279:46843-50.
77. Kurokawa K, Matsuda M. Localized RhoA activation as a requirement for the induction of membrane ruffling. Mol Biol Cell 2005;16:4294-303.
78. Nakayama K, Ishida N, Shirane M, et al. Mice lacking p27(Kip1) display increased body size,mult iple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996;85:707-20.